menu search

Hacu announces eleven honorees to be recognized at 37th annual conference on hispanic higher education, oct. 28-30, 2023

SAN ANTONIO, Oct. 20, 2023 (GLOBE NEWSWIRE) — The Hispanic Association of Colleges and Universities has announced 11 honorees will be recognized for...

October 20, 2023, 3:15 pm

Ey announces jim mortensen of r3 continuum as an entrepreneur of the year® 2023 heartland award finalist

Entrepreneur Of The Year celebrates ambitious entrepreneurs who are building bolder futures MINNEAPOLIS, May 10, 2023 (GLOBE NEWSWIRE) — Ernst & You...

May 10, 2023, 2:11 pm

Harmony biosciences to present new wakix® (pitolisant) safety and efficacy data at sleep 2023 annual meeting

Late-breaking Phase 2 proof-of-concept study in Prader-Willi syndrome accepted for poster presentation PLYMOUTH MEETING, Pa. , May 10, 2023 /PRNewswir...

May 10, 2023, 8:05 am

David wellisch, ceo of cultural intelligence leader collage group, honored as entrepreneur of the year® 2023 mid-atlantic award finalist

Entrepreneur of The Year celebrates ambitious entrepreneurs who are building bolder futures. Washington, D.C., May 04, 2023 (GLOBE NEWSWIRE) — Ernst...

May 4, 2023, 3:35 pm

Nauticus robotics to speak at 37th edition of sxsw conference and festival

CEO Nic Radford to Discuss Entrepreneurship and Innovation in Houston HOUSTON, March 09, 2023 (GLOBE NEWSWIRE) — Nauticus Robotics, Inc. (“Nauticu...

March 9, 2023, 5:00 pm

Agenus to present botensilimab data in oral plenary session at the society of gynecologic oncology 2023 annual meeting on women’s cancer

LEXINGTON, Mass., Feb. 28, 2023 (GLOBE NEWSWIRE) — Agenus (Nasdaq: AGEN), a clinical-stage company with a pipeline of therapies designed to activate...

February 28, 2023, 12:30 pm

Jushi holdings opens fifth medical cannabis dispensary in virginia; 37th retail location in the us

Jushi Holdings Inc (CSE:JUSH, OTCQX:JUSHF) has announced the opening of its fifth medical cannabis dispensary in Virginia and ...

January 17, 2023, 8:41 am

Predicine to introduce predicinecomplete™, its genome-wide liquid biopsy solution, at the society for immunotherapy of cancer (sitc) 37th annual meeting

SILICON VALLEY, Calif., Nov. 10, 2022 (GLOBE NEWSWIRE) — Predicine, a global molecular insights company, announces the introduction of PredicineCOMP...

November 11, 2022, 2:00 am

Bicycle therapeutics to present five posters highlighting preclinical data from its bicycle tumor-targeted immune cell agonist® (bicycle tica®) programs at the sitc 37th annual meeting

CAMBRIDGE, England, & BOSTON--(BUSINESS WIRE)--Bicycle Therapeutics plc (NASDAQ:BCYC), a biotechnology company pioneering a new and differentiated cla...

November 10, 2022, 9:09 am

Masonic cancer center, university of minnesota to present data in poster presentation from the phase 1 clinical trial to evaluate hcw9218 in solid tumors at the sitc 37th annual meeting

Presentation includes data on safety and dosage escalationand immune system reaction to HCW9218 No incidence of mucosal bleeding resulting from the HC...

November 8, 2022, 12:00 pm

Medivir to present data on additive efficacy of fostrox in combination with anti-pd1 in nonclinical tumor models at the sitc 2022 annual meeting

STOCKHOLM , Sept. 8, 2022 /PRNewswire/ -- Medivir AB (Nasdaq Stockholm: MVIR), a pharmaceutical company focused on developing innovative treatments fo...

September 8, 2022, 3:33 am

Genentech to present new data on ocrevus (ocrelizumab) in multiple sclerosis and enspryng (satralizumab-mwge) in neuromyelitis optica spectrum disorder at ectrims 2021

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that new Ocrevus® ...

October 5, 2021, 1:00 am

Roche to present new data on ocrevus in multiple sclerosis and enspryng in neuromyelitis optica spectrum disorder at ectrims 2021

Basel, 5 October 2021 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that new OCREVUS® (ocrelizumab) and ENSPRYNG® (satralizumab) data will be...

October 5, 2021, 1:00 am

Genentech to present new data on ocrevus (ocrelizumab) in multiple sclerosis and enspryng (satralizumab-mwge) in neuromyelitis optica spectrum disorder at ectrims 2021

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that new Ocrevus® ...

October 5, 2021, 1:00 am

Genentech to present new data on ocrevus (ocrelizumab) in multiple sclerosis and enspryng (satralizumab-mwge) in neuromyelitis optica spectrum disorder at ectrims 2021

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that new Ocrevus® ...

October 5, 2021, 1:00 am

Genentech to present new data on ocrevus (ocrelizumab) in multiple sclerosis and enspryng (satralizumab-mwge) in neuromyelitis optica spectrum disorder at ectrims 2021

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that new Ocrevus® ...

October 5, 2021, 1:00 am

Genentech to present new data on ocrevus (ocrelizumab) in multiple sclerosis and enspryng (satralizumab-mwge) in neuromyelitis optica spectrum disorder at ectrims 2021

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that new Ocrevus® ...

October 5, 2021, 1:00 am

Roche to present new data on ocrevus in multiple sclerosis and enspryng in neuromyelitis optica spectrum disorder at ectrims 2021

Basel, 5 October 2021 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that new OCREVUS® (ocrelizumab) and ENSPRYNG® (satralizumab) data will be...

October 5, 2021, 1:00 am

Genentech to present new data on ocrevus (ocrelizumab) in multiple sclerosis and enspryng (satralizumab-mwge) in neuromyelitis optica spectrum disorder at ectrims 2021

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that new Ocrevus® ...

October 5, 2021, 1:00 am

Genentech to present new data on ocrevus (ocrelizumab) in multiple sclerosis and enspryng (satralizumab-mwge) in neuromyelitis optica spectrum disorder at ectrims 2021

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that new Ocrevus® ...

October 5, 2021, 1:00 am


Search within

Pages Search Results: